Pathological mechanisms and treatment of sporadic Parkinson’s disease: past, present, and future
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Pathological mechanisms and treatment of sporadic Parkinson’s disease: past, present, and future ; volume:131 ; number:6 ; day:12 ; month:6 ; year:2024 ; pages:597-607 ; date:6.2024
Journal of neural transmission ; 131, Heft 6 (12.6.2024), 597-607, 6.2024
- Creator
-
Mochizuki, Hideki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00702-024-02788-w
- URN
-
urn:nbn:de:101:1-2409122127397.839863165735
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mochizuki, Hideki
- SpringerLink (Online service)
Other Objects (12)
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
Neuroanatomy and pathology of sporadic Parkinson's disease
Modeling Neuroinflammation in sporadic Parkinson ́s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
A reversible state of hypometabolism in a human cellular model of sporadic Parkinson’s disease
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
Neuroanatomy and pathology of sporadic Parkinson's disease
Modeling Neuroinflammation in sporadic Parkinson ́s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
A reversible state of hypometabolism in a human cellular model of sporadic Parkinson’s disease
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
Neuroanatomy and pathology of sporadic Parkinson's disease
Modeling Neuroinflammation in sporadic Parkinson ́s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
A reversible state of hypometabolism in a human cellular model of sporadic Parkinson’s disease
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology